« Back to Record
Citation APA

Chang, C. A., Jen, J., Jiang, S., Sayad, A., Mer, A. S., Brown, K. R., Nixon, A. M. L., Dhabaria, A., Tang, K. H., Venet, D., Sotiriou, C., Deng, J., Wong, K. K., Adams, S., Meyn, P., Heguy, A., Skok, J. A., Tsirigos, A., Ueberheide, B., Moffat, J., Singh, A., Haibe-Kains, B., Khodadadi-Jamayran, A., & Neel, B. G. (2022). Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. Cancer Discovery, 12(4), 1022-1045. doi:10.1158/2159-8290.CD-20-1265


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/353892

Chang, C. A., Jen, J., Jiang, S., Sayad, A., Mer, A. S., Brown, K. R., Nixon, A. M. L., Dhabaria, A., Tang, K. H., Venet, D., Sotiriou, C., Deng, J., Wong, K. K., Adams, S., Meyn, P., Heguy, A., Skok, J. A., Tsirigos, A., Ueberheide, B., Moffat, J., Singh, A., Haibe-Kains, B., Khodadadi-Jamayran, A., & Neel, B. G. (2022). Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer. Cancer Discovery, 12(4), 1022-1045. doi:10.1158/2159-8290.CD-20-1265